CPHI Milan 2026

EDITORIAL SECTION

  • STRATEGY

    Smarter Pharma

    Quality management systems QMS are the backbone of pharmaceutical manufacturing ensuring safe products

  • EXPERT Talk

    Compliance to Competitive Advantage in Pharma Supply

    Compliance gets you through an audit Resilience gets medicines to patients on the day something unexpected happens The DSCSAs enhanced requirements took effect November but real interoperability required three more rounds of accommodation phased implementation with the smalldispenser

KNOWLEDGE BANK

  • Articles

    How Digitalization Improves Pharma Manufacturing and Compliance

    The pharmaceutical industry has been at a crossroads where the digitalization process is transforming the way drugs are developed manufactured and monitored Pharmaceutical companies are capitalizing on the power of digitalization in pharmaceutical production to maximize production improve traceability and regulatory compliance due to the tough regulatory requirements and the demand for absolute pr...

    Clinical Trials: Failures and Challenges on the Path to Treating Alzheimer’s

    Alzheimers disease AD is a neurodegenerative disorder with symptoms of memory loss and cognitive disability Typically it begins with mild symptoms that progress to become more severe AD is the th leading cause of death in the United States among people or older In million Americans suffered from AD and this is expected to rise to million by

    What Are the Benefits of Implementing a Modern MES in Pharma?

    The pharmaceutical sector is rapidly changing in a bid to match the increasing pressure of regulation attain perfection in product quality and hasten the timetomarket A Pharma MES or Manufacturing Execution System is one of the most strategic investments that are strategically placed in this environment in terms of operational excellence

    Key Stages in Pharmaceutical Formulation Development: A Complete Guide

    One of the most significant operations in the field of drug study is pharmaceutical formulation development to ensure that the medications are distributed to the patients without harm and in the most appropriate manner This is a science that involves the transformation of an active pharmaceutical ingredient API into a solid efficient and convenient dosage form To researchers manufacturers and regu...

    Role of QSAR in filling in the gaps of CoVID-19 Therapeutics

    Since initial reports from Wuhan China in December and the subsequent declaration of a global pandemic by the WHO in March CoVID has precipitated the greatest health crisis in modern history While exposing fundamental weaknesses in healthcare systems across the globe this tragedy has also been an opportunity for scientists and researchers in different fields to collaborate and produce solutions...

    Therapeutic Intervention of Polymeric Nanoparticles Combining Bone Marrow Stem Cells for the treatment of Alzheimer’s disease

    Alzheimers disease ADis a neurological disorder that is responsible for brain atrophy and neuronal degeneration resulting in a decline in thinking ability and behaviour The progressive neurodegeneration leads to memory loss or dementia which makes it difficult to carry out daytoday tasks and it also has an impact on the socializing ability of the individual

TOP ARTICLES

  • 4

    Role of QSAR in filling in the gaps of CoVID-19 Therapeutics

    Smriti Sharma Bhatia

    Yousuf Khan

    Kunika Saini

    QSAR modelling has been used extensively as an efficient method in the process of drug development against CoVID-19. The rapid spread and devastating impact of this viral disease across the globe requ...

press releases Read more...

Thewaico Emerges from Stealth with Bioreactor Platform Built to Address Biomanufacturing's Massive Scale-Up Problem

Thewaico a bioprocess innovation company today emerged from stealth with an integrated bioreactor and bioprocess control platform developed to address one of biomanufacturings most persistent and costly failures

Seasoned Biotech Finance Executive Florian Schmid Appointed CFO of T-CURX to Support Next Phase of Growth

TCURX GmbH TCURX a biotechnology company developing nonviral CART therapies today announced the appointment of Florian Schmid as Chief Financial Officer Florian will lead the company

Pharmazz, Inc. Receives U.S. FDA IND Clearance to Initiate Phase 3 Clinical Trial of Sovateltide in Traumatic Brain Injury

Pharmazz Inc Pharmazz or the Company a latestage biopharmaceutical company focused on developing and commercializing firstinclass therapeutics for critical care and neurological conditions

Genentech’s Fenebrutinib Is the First BTK Inhibitor to Receive U.S. FDA Filing Acceptance in Both Relapsing and Primary Progressive Multiple Sclerosis

Genentech a member of the Roche Group SIX RO ROP OTCQX RHHBY announced today that the US Food and Drug Administration FDA has accepted the companys New Drug Application NDA under

05 - 06

Oct 2026

ISPSAI France 2026

Paris, France

05 - 08

Oct 2026

12 - 13

Oct 2026

Pharmaceutics 2026

Village Hotel Changi, Singapor...

12 - 13

Oct 2026

2nd International Conference on Drug Discovery

Village Hotel Changi, Singapor...

21 - 23

Oct 2026

21 - 22

Oct 2026

22 - 23

Oct 2026

PDA Aseptic Symposium 2026

Congress Square Nakanoshima, O...

26 - 28

Oct 2026

ACHEMA Middle East 2026

RICEC, Riyadh, KSA, Saudi Arab...

LATEST NEWS Read more...

Fresenius completes acquisition of mAbxience

Fresenius SE Co KGaA has completed the acquisition of the remaining stake in mAbxience from Insud Pharma giving Fresenius full ownership of the biopharmaceutical company

R1 Therapeutics expands Series A financing to $80.5 million

R Therapeutics has expanded its Series A financing to million with new investment from Samsara BioCapital The clinicalstage biopharmaceutical company will use the funding to advance AP

Immunome receives FDA clearance for IM-1340 clinical trial

Immunome has received clearance from the US Food and Drug Administration FDA for its Investigational New Drug IND application for IM an investigational antibodydrug conjugate ADC being developed for advanced solid tumours

Novonesis Expands West Allis Facility to Strengthen North American Dairy Production

Novonesis has completed a major expansion of its production facility in West Allis Wisconsin increasing its North American capacity for dairy cultures The investment has raised fermentation capacity

4basebio and TriLink BioTechnologies Partner to Support Phase I Cell Therapy Programme

basebio has announced a partnership with TriLink BioTechnologies to support a Phase I cell therapy programme being developed by a multinational pharmaceutical company

Astoriom Acquires Additional UK Storage Business to Expand Capacity and Services

Astoriom has acquired Roylance Stability Storage Limited and Roylance Scientific Limited the UK operations of life sciences stability storage provider Sampled based in Glasgow The acquisition expands